NCT04572633View on ClinicalTrials.gov

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy

NAActive, not recruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

January 9, 2023

Study Completion Date

September 30, 2027

Conditions
Liver NeoplasmsHepatocellular CarcinomaLiver Metastases
Interventions
DEVICE

HistoSonics System

The HistoSonics System (System) is intended for the destruction of liver tissue using histotripsy, a non-thermal, mechanical process using focused ultrasound.

Trial Locations (7)

33176

Miami Cancer Institute, Miami

33606

Tampa General Hospital, Tampa

53226

Medical College of Wisconsin/Froedtert Hospital, Milwaukee

60637

University of Chicago, Chicago

66160

University of Kansas Medical Center, Kansas City

48109-5030

University of Michigan Hospital, Ann Arbor

53792-3252

University Hospital - UW Health, Madison

Sponsors

Lead Sponsor

HistoSonics, Inc.
All Listed Sponsors
lead

HistoSonics, Inc.

INDUSTRY

NCT04572633 - The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy | Biotech Hunter | Biotech Hunter